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S U M M A R Y
Objectives: Participant-collected serial nasal swabs would be a cost-efﬁcient feature of prospective
population-based microbiological studies. We examined the feasibility of serial anterior nasal self-
swabbing for Staphylococcus aureus detection in a prospective population-based study in Braunschweig,
Germany, and assessed the impact of three interventions on participation and compliance.
Methods: Two thousand twenty-six inhabitants were selected randomly from the resident registries and
asked to self-collect a nasal swab monthly from July 2012 to January 2013 and return it by mail. The
swabs were tested for the presence of S. aureus. Participation and compliance were assessed in four study
groups (incremental cash incentive, participation in a lottery, reminder by mail, and control group
without incentive or reminder).
Results: Baseline participation was highest in the cash incentive group (24%; 123/504) and lowest in the
reminder group (16%; 83/509). Approximately 90% of the participants in all groups returned the swabs
each month, demonstrating high compliance irrespective of the intervention. Laboratory analyses
showed that most swabs were usable for bacteriological studies. S. aureus was detected at the expected
frequency of 20–27%.
Conclusions: Home-based serial nasal self-swabbing proved to be feasible and highly acceptable and
promises to be a cost-efﬁcient tool for large-scale prospective population-based studies on bacterial
infection or colonization.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Collecting biological specimens is becoming an increasingly
frequent feature of epidemiological studies, likely due to the rapid
development of assays for the quantiﬁcation of biomarkers and
other molecular-deﬁned variables.1 However, the high cost of
collection methods requiring face-to-face contact of study
personnel with participants may limit the feasibility of collecting
certain types of biospecimens. This is especially problematic in
prospective studies requiring serial sample collection. An alterna-
tive would be to ask the participants to self-collect certain
biosamples, such as nasal swabs, vaginal swabs, saliva, or capillary* Corresponding author. Tel.: +49 (0)5316181 3103.
E-mail address: manas.akmatov@helmholtz-hzi.de (M.K. Akmatov).
http://dx.doi.org/10.1016/j.ijid.2014.01.021
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).blood samples, at home and return them by mail. Self-collection
may thus greatly reduce costs and also be more acceptable to the
participants. The lower cost of this method may also facilitate
studies involving large populations.2
Several, mainly cross-sectional, studies have applied self-
collection in various settings. Studies have shown adequate quality
and quantity of DNA in self-collected saliva3,4 and vaginal samples5
that were returned by mail. Self-collection of nasal swabs to
measure the prevalence of methicillin-sensitive and methicillin-
resistant S. aureus (MSSA and MRSA) carriage has been applied in
several cross-sectional studies.6–8 It has also been used to detect
respiratory pathogens in prospective cohort studies spanning one
acute respiratory infection (ARI) season. For instance, nurses have
collected their own nasal swabs,9 and parents have collected nasal
swabs from their children.10 We have asked adult participants to
self-collect nasal swabs in two prospective studies on viralciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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developed ARI symptoms, amounting to up to three swabs per ARI
season. However, serial nasal self-swabbing has not been applied
in longitudinal population-based studies. In particular, there are no
such studies in ‘unsupervised settings’, i.e. scenarios not involving
at least some face-to-face contact between the participants and
study personnel. Thus, it is unknown (1) whether participants will
comply with such demanding study designs, and (2) how
participation and/or compliance can be optimized in such studies.
We therefore examined the feasibility of collecting serial nasal self-
swabs by mail in an unsupervised setting and also assessed the
impact of any of three interventions (an incremental cash
incentive, participation in a lottery, and reminder by mail),
compared to a control group, on participation and compliance.
2. Methods
2.1. Sampling and study participants
We conducted a prospective population-based study over a
period of 6 months (July 2012 to January 2013). A local public
relations campaign was conducted 1 week before sending out the
invitation to participate in the study. The campaign featured a
press release (leading to coverage in local newspapers), an
interview for a local radio newscast, and posting of a podcast on
the institution’s internet page. Potential participants, males and
females between 20 and 69 years of age (n = 2026), were selected
randomly through the resident registration ofﬁce and invited with
a personalized letter to participate in the study.Figure 1. Schematic presentation of the study design. (1) Total sample selected randomly
participate). (4) Monthly self-swabbing (*returned at least one swab) and non-responde
was not collected.In accordance with the envisaged age and sex distribution of the
German National Cohort13 (for which studies on S. aureus
dynamics in the community are planned), the proportion of older
participants (age groups 40–49, 50–59, and 60–69 years) was
oversampled (26.7% in each age group vs. 10% in the age groups
20–29 and 30–39 years). Individuals were asked to self-collect a
nasal swab every month and mail it to the laboratory within 48 h of
self-swabbing. Since a major aim of the study was to detect S.
aureus carriage patterns, it was planned to collect seven swabs over
a period of 6 months.14 Individuals were assigned by block
randomization to one of the following four groups: (1) incremental
cash incentive, also referred to as the ‘cash incentive’ group; (2)
participation in a lottery, aka ‘lottery’ group; (3) reminder by mail,
aka ‘reminder’ group; and (4) a control group. Approximately 500
invitees were included in each group. The participants in the cash
incentive group were successively awarded 1s, 3s, 5s, 7s, 9s,
and 11s for each returned swab (starting from the second swab),
resulting in a total of 36s to be paid upon completion of the study.
Participants in the lottery group had a chance to win 20s, 30s, or
50s each month in which they returned the swab. The reminder
group received a short reminder letter by mail approximately 2
weeks after the monthly self-swabbing kit if the requested swab
was not received by the laboratory. The control group received
neither the promise of an incentive nor a reminder letter. Separate
invitation letters and information brochures were designed for
each of the four study groups, ensuring that the participants in
each group were blinded to the existence of the other three study
arms. These strategies could have affected the participants’ initial
willingness to join the study (participation) as well as their
subsequent compliance with the study protocol, because each from the resident registration ofﬁce. (2) Invitation sent. (3) Response (agreement to
r survey. **Information about the assignment of non-responders to the study arms
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describing the study that was sent out to the individuals to be
recruited into the respective groups. Those who were willing to
participate in the study were asked to return an enclosed stamped
postcard and the signed informed consent form.
Basic socio-demographic data (e.g. sex, age, education, self-
perceived health status, chronic diseases, and other common risk
factors for S. aureus colonization), as well as information on
comprehension of the instructions and acceptance of the self-
collection of nasal swabs, were collected at baseline through a self-
administered questionnaire that was sent out with the ﬁrst self-
swabbing kit.
Participants were provided with written and visual instructions
on how to self-collect an anterior nasal swab. Each month an
envelope was sent to the participant that contained the following
items: a swabbing kit containing an Amies gel swab (Copan, Italy;
catalog No. 108C), a short questionnaire, instructions for self-
swabbing of the anterior nares, and a return envelope. In brief, the
swab was to be inserted into one nostril to a depth of 1 cm, rotated
three times on the nasal lining, and then placed into the transport
medium. A schematic of the study design is shown in Figure 1.
2.2. Ethical and data safety approval
The study was approved by the Ethics Committee of the State
Board of Physicians of the German Federal State of Lower Saxony
and the Federal Commissioner for Data Protection and Freedom of
Information of the Federal Republic of Germany.
2.3. Feasibility, compliance, and acceptance
The feasibility of serial self-collection of nasal swabs by mail
was assessed by the following parameters: (1) the proportion of
participants who had difﬁculties understanding the self-swabbing
instructions (asked only at baseline), (2) the proportion of
participants who reported deviations from the suggested self-
swabbing procedure, (3) time from dispatch to arrival of the swab
in the laboratory, and (d) time from self-collection to arrival of the
swab in the laboratory. Each month the participants’ compliance
with serial self-collection was assessed by the proportion of
returned swabs. Acceptance of self-collection of nasal swabs was
assessed with the following questions on a Likert scale with ﬁveTable 1
Descriptive characteristics of responders (by group) and non-responders in the study (
Characteristics Cash incentive group
n = 123
Lottery group
n = 109
Reminder grou
n = 83
Sex
Female 68 51 64 
Male 32 49 36 
Age, years, median (IQR) 47 (38–59) 51 (40–62) 50 (39–63) 
Level of school leaving qualiﬁcation
Lower 20 22 25 
Middle 36 35 34 
Higher 44 43 41 
Self-perceived health status
Poor/fair 10 9.0 10 
Good 61 65 62 
Very good/excellent 29 26 28 
BMI, kg/m2, median (IQR) 25.3 (22.6–28.4) 25.2 (22.4–28.1) 24.9 (22.0–26.
Country of birth
Germany 87 94 96 
Other 13 5.8 3.7 
IQR, interquartile range; BMI, body mass index.
a Percentages are rounded so that uniform numbers of signiﬁcant ﬁgures are shown
b Chi-square test for differences across groups.
c There were six missing values spread across variables.
d Chi-square test for differences between responders and non-responders.
e Wilcoxon signed rank test.answer categories: ‘‘Collecting the nasal swab myself was
acceptable’’, ‘‘I felt uncomfortable when taking the swab myself’’,
and ‘‘Nasal self-swabbing was easy to perform’’. These questions
were asked twice, i.e. at baseline and in study month 3.
2.4. Laboratory analysis
Nasal swabs were inoculated on blood agar (Mueller–Hinton II
agar with 5% sheep blood; BD Diagnostics 254 080) and MRSA agar
(Chrome agar II MRSA; BD Diagnostics 257 434). The plates were
incubated overnight (approximately 18 h) at 37 8C. The appearance
of the colonies on the blood agar plates was recorded (0 = no
growth; 1 = rare; 2 = light; 3 = moderate; 4 = heavy). Colonies with
the appearance of S. aureus were then subcultured on blood agar
and tested with a slide coagulase test. Human blood plasma
received from a local hospital and ﬁbrinogen from human blood
plasma (Sigma-Aldrich, USA) were used for coagulase testing. DNA
was extracted with the DNeasy Blood and Tissue Kit (Qiagen). PCR
for the spa gene was used to conﬁrm the diagnosis of S. aureus.15
2.5. Non-responder survey
A short anonymous questionnaire was sent to 1480 non-
responders. This questionnaire could not be sent to the other non-
responders, because the initial invitation was undeliverable due to
incorrect address information. The questionnaire contained
questions on basic socio-demographics, common risk factors for
S. aureus carriage, and reasons for not participating in the study.
2.6. Statistical analysis
Associations between categorical variables were tested with
the Chi-squared test. Differences in continuous variables across
various groups were tested with the Wilcoxon signed rank test. The
effect of the interventions on compliance was examined with
repeated measures logistic regression using the generalized
estimating equations procedure. The model was adjusted for
participant age, sex, and level of school-leaving qualiﬁcation.
Semiparametric group-based modeling was used to classify
participants into compliance trajectories (the SAS procedure PROC
TRAJ).16 We started with a single trajectory and subsequently
increased the number of trajectories by one until we reached the%)a
p Control group
n = 90
p-Valueb All responders
n = 405
Non-responders
n = 274c
p-Valued
61 0.08 61 53 0.05
39 39 47
50 (38–60) 0.63e 49 (39–61) 50 (38–62) 0.59
23 0.97 22 26 0.31
31 34 36
46 44 38
7.0 0.92 9.2 14 0.03
70 64 55
23 27 31
9) 25.2 (22.6–27.1) 0.68e 25.1 (22.5–27.8) 24.8 (22.5–28.0) 0.94
92 0.09 92 NA NA
8.0 8.0 NA
.
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criterion.16
3. Results
3.1. Participation rate and sample characteristics
The initial overall participation rate was 20% (405/2026). The
highest participation was observed in the cash incentive group
(24%; 123/504), followed by the lottery (22%; 109/508), control
(18%; 90/505), and reminder (16%; 83/509) groups (Chi-square =
12.627, df = 3, p = 0.006). We observed only minor differences
across groups in selected socio-demographic variables (Table 1).
Of the 1480 individuals to whom a non-responder question-
naire was sent, 274 (19%) returned the completed questionnaire.
The proportions of male participants and of individuals who
reported poor/fair health status were signiﬁcantly lower in the
study sample than in the non-responder sample (Table 1). None of
the other variables (e.g. age, education, and body mass index)
differed signiﬁcantly between responders and non-responders.
The most commonly reported reasons for not participating in the
study were ‘lack of time’ (41%), ‘no interest’ (13%), ‘I was not
convinced by the aims of the study’ (5.9%), ‘language difﬁculties’Figure 2. Compliance in the four groups (incremental cash incentive, participation in 
measured by the proportion of nasal swabs returned each month. Reminder letters were 
in month 1 and because of holidays in month 5 (December 2012).(4.1%), and other reasons (24%). No speciﬁc reason was provided
in 12%.
3.2. Feasibility
About 98% (381/388) of the participants reported no difﬁculties
understanding the self-swabbing instructions (asked at baseline).
The proportion of participants who reported a deviation in the self-
swabbing procedure was highest at baseline (2.1%, 8/386) and
lowest in study month 6 (0.53%, 2/375). The reported difﬁculties
were (1) the top of the swab touched something else (e.g. edge of
the table), and (2) the swab fell on the ﬂoor. Across all months, the
median time between dispatch of the monthly swab kits and
receipt of the swabs in the laboratory was 6 days (range 1–65,
interquartile range (IQR) 5–8 days). The median time between self-
swabbing and arrival of the swabs in the study center was 1 day
(range 0–36, IQR 1–2 days). Ninety-nine percent of the nasal swabs
(2634/2656) were returned within 1 week of self-swabbing.
3.3. Compliance
Compliance with serial self-swabbing (as measured by the
proportion of returned swabs) was high in all months (Figure 2). Of
the 405 participants, 396 (98%) returned at least one nasal swaba lottery, reminder by mail, and control group) by study month. Compliance was
not sent in study months 1 and 5 because of a high return rate in the ﬁrst two weeks
Figure 3. Compliance trajectories over the study period (n = 405). Compliance was
measured by the proportion of nasal swabs returned each month. Trajectories were
identiﬁed using the SAS procedure PROC TRAJ as outlined in the Methods. Solid lines
indicate the estimated trajectory probability; dashed lines indicate the measured
trajectory probability. Only one line is visible in the case of persistently perfect
compliance due to coincidence of the two lines.
Table 2
Bacterial growth scorea
Mean growth scoreb (range, IQR)
Baseline swab (n = 367) 3.1 (0–4, 3–4)
Swab at month 1 (n = 361) 3.3 (0–4, 3–4)
Swab at month 2 (n = 382) 3.2 (0–4, 3–4)
Swab at month 3 (n = 362) 2.7 (0–4, 2–4)
Swab at month 4 (n = 359) 2.6 (0–4, 2–4)
Swab at month 5 (n = 365) 2.5 (0–4, 2–3)
Swab at month 6 (n = 352) 2.5 (0–4, 2–3)
IQR, interquartile range.
a A score was not recorded for plates with Proteus spp overgrowth.
b The appearance of the colonies on blood agar plates was scored as follows: 0 =
no growth; 1 = rare; 2 = light; 3 = moderate; 4 = heavy.
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There were no statistically signiﬁcant differences in compliance
across the four study groups (Figure 2). Older participants were
somewhat more likely to return a nasal swab than younger
participants (increase of odds per year of age: odds ratio 1.04, 95%
conﬁdence interval 1.01–1.07). Three compliance trajectories were
estimated using semiparametric group-based modeling (Figure 3):
persistently perfect compliance (87%), initial high but decreasing
compliance (8.0%), and initial low and decreasing compliance
(4.7%).
3.4. Acceptance
Ninety-nine percent (335/338) of the participants reported that
nasal self-swabbing was acceptable or highly acceptable and 0.89%
reported ‘not sure’; no one reported disagreement with this
statement. Ninety percent (305/338) reported no difﬁculties when
self-collecting the swab, 11 (3.3%) were not sure, and 22 (6.5%)
reported that they felt uncomfortable. Of the 340 participants, 335
(99%) stated that nasal self-swabbing was easy to perform, one
(0.29%) was not sure, and four (1.2%) disagreed with this
statement. No signiﬁcant differences were observed in the second
questionnaire administered 3 months later.
3.5. Laboratory ﬁndings
The mean colony density varied between 2.5 and 3.3 across the
study months (Table 2). The proportion of nasal swabs with no
bacterial growth varied between 0.77% (3/389, baseline) and 5.6%Table 3
Bacterial growth observed on blood agar plates (%)a,b
Baseline swab
n = 390
Swab at month 1
n = 384
Swab at month 2
n = 386
No growth 0.77 1.6 2.6 
Staphylococcus aureusc 22 22 19 
Other bacteria 77 74 78 
a Percentages are rounded so that uniform numbers of signiﬁcant ﬁgures are shown
b Values represent percentages of all swabs received in the time period speciﬁed, ba
c Conﬁrmed by PCR.(21/377, month 4) (Table 3). The proportion of swabs positive for S.
aureus varied between 20% and 27% (Table 3).
4. Discussion
Serial nasal self-swabbing, an equally desirable and demanding
component of community-based studies on bacterial colonization
and infection, turned out to be a feasible and highly acceptable
method in this short-term, prospective, population-based study.
4.1. Comparison of the three schemes to enhance participation and
compliance
The monetary and lottery incentives were associated with
higher participation rates. This is consistent with previous
observations that showed positive effects of monetary and non-
monetary incentives on participation rates.17 The reluctance of
some participants to receive monthly reminder postcards might be
responsible for the slightly lower participation rate in the reminder
group. Interestingly, the three intervention strategies were not
associated with differences in compliance with the self-swabbing
protocol, suggesting that less obvious rewards not measured here,
or an intrinsically high motivation, governed the participants’
study behavior once they had decided to join the study. We favor
the latter possibility, as compliance was high throughout the
duration of the study. Age was the only variable signiﬁcantly
associated with better compliance.
These ﬁndings are of particular importance since substantial
savings would result if costly incentives and/or reminders are not
needed in a large population-based study. These savings would be
particularly noticeable in large population-based studies involving
thousands of participants, such as genome-wide association
studies of nasal S. aureus carriage.18 Interestingly, previous
research on retention methods in prospective population-based
studies lasting up to several years showed that both monetary
incentives and reminders increased retention rates.19 However, by
receiving self-swabbing kits on a monthly basis, the participants in
all four study groups were exposed to a continual alerting system.
Moreover, our study was of relatively short duration, and theSwab at month 3
n = 384
Swab at month 4
n = 378
Swab at month 5
n = 378
Swab at month 6
n = 375
3.6 5.6 3.4 4.5
23 23 27 24
73 72 70 72
.
sed on inspection of bacterial growth.
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longer study period.
4.2. Feasibility, acceptance, and compliance
Most participants (99%) returned the nasal swabs within 1 week
of self-swabbing. This is important since a longer time from self-
collection to the arrival of the swab in the laboratory may have a
negative impact on pathogen detection. Baay et al. examined the
effect of shipping time on the quality of genomic DNA in self-
collected vaginal swabs5 and found that a longer shipping time
resulted in a marginal decrease in DNA yield. However, the trend
was not signiﬁcant and the amount of DNA was sufﬁcient for
analysis.5 In a previous study of nasal self-swabbing to detect acute
viral respiratory pathogens with PCR, we found no association
between shipping time and positivity rate.11 Delacour et al.
examined the survival of S. aureus strains in the Amies swab
transport system (which we used in the present study) and found
that S. aureus can survive for up to 3 weeks during transport at
room temperature.20 However, the authors recommend a time
frame of 18 days between swab collection and laboratory analysis
for optimal isolation of S. aureus strains.20 As mentioned above,
nearly all swabs in the current study were returned within 1 week.
We observed an interesting pattern regarding compliance
changes over the study period. The overwhelming majority of
participants showed consistently perfect compliance by sending in
all scheduled nasal swabs during the study period, and compliance
decreased in only a small proportion of participants. Such very high
compliance with serial self-collection of nasal swabs in popula-
tion-based longitudinal studies would certainly facilitate conduct-
ing studies on bacterial carriage/infection patterns and their risk
factors; ﬁrst, by substantially lowering study expenses because
costly home visits or visits to the study center are avoided, and
second, by providing an uninterrupted chain of sequential swabs.
For example, individuals may be permanently, transiently, or not at
all colonized with S. aureus, and persistent carriers are at higher
risk of developing invasive infections.21 However, the underlying
risk factors for these different colonization patterns are not well
understood, and serial self-collection of nasal swabs would allow
capturing of the relevant phenotypes in the general population.
4.3. Strengths and limitations
This is the ﬁrst prospective population-based study to use serial
nasal self-swabbing and swab remittance by mail without any
direct contact between staff and participants. Previous studies
have used self-collection of nasal swabs mainly in cross-sectional
approaches,8,22,23 and the small number of prospective studies
used it to detect viral acute respiratory pathogens.10,24 The latter
studies applied self-collection of nasal swabs if participants
developed an acute respiratory episode during an ARI season.
Peltola et al. used serial self- or parent-collected nasal swabs in a
short-term prospective study of hospitalized individuals to
examine the shedding patterns of rhinoviruses; the participants
were asked to self-collect a nasal swab twice a week over a period
of 3 weeks.25 In that study, the study personnel instructed the
participants in the self-swabbing technique during the initial
recruitment visit. In contrast, in the present study all communica-
tion with the participants, including recruitment, data collection,
and feedback of personal results, took place by mail, and the
participants learned the self-swabbing procedure through the
instruction brochure. This is especially important since many
individuals may not want to participate in epidemiological studies
due to a lack of time or because they are reluctant to engage in
personal contact with study personnel. Self-collection in a home-
based setting would be an alternate option for such individuals. Inaddition, avoiding travel to the study center or expensive
communication tools such as email would be favorable for
implementing nasal self-swabbing in studies in resource-poor
countries.
Our study is limited by the possibility that the study sample
may not be representative of the source population, since the
participation rate was only 20%. Indeed, the proportions of men
and of individuals with a poor health status were lower in the
responder than the non-responder samples. Another possible
limitation is that we did not examine the validity of the self-
collected swabs to detect S. aureus carriage by comparing it with
the gold standard, e.g. a staff-collected swab. However, self-
collection of nasal swabs has been shown to be a valid method to
detect viral12,26,27 and bacterial infections28,29 in various settings.
van Cleef et al. compared the detection of S. aureus in self- and
staff-collected nasal swabs among nursing and technical staff and
observed high agreement (93%, kappa coefﬁcient 0.85).29 The
detection rate of S. aureus was even higher in self- than in staff-
collected swabs.29 Lautenbach et al. observed similar results in a
hospital-based study.28 Both studies revealed a high sensitivity of
nasal self-swabs to detect S. aureus compared to the gold
standards, ranging from 91%28 to 97%.29 Moreover, in a previous
study of nasal self-swabbing, we observed that self-collected
swabs are qualitatively as good as those collected by a trained staff
member, as measured by the levels of human b-actin gene DNA
sequences and pathogen detection rates.11 The current study
showed that the vast majority of nasal swabs were usable for
bacteriological culture; there was only a small proportion of swabs
that provided no bacterial growth at all. In addition, the S. aureus
detection rate of 20–27% was similar to previous reports.30,31
In conclusion, serial self-collection of nasal swabs proved to be a
feasible and highly acceptable method in a prospective population-
based study. Monetary incentives were associated with higher
participation, but compliance was excellent irrespective of
incentives or reminders. Serial self-collection of nasal swabs
without costly incentives or reminders thus promises to be a cost-
efﬁcient tool for large-scale population-based studies examining
infections and/or colonization of the upper respiratory tract.
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